These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18078566)

  • 1. Scheduling mammography screening for the early detection of breast cancer in Korean women.
    Lee SY; Jeong SH; Kim J; Jung SH; Song KB; Nam CM
    J Med Screen; 2007; 14(4):205-9. PubMed ID: 18078566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on scheduling periodic examinations for the early detection of breast cancer in Korea].
    Jeong SH; Kang DR; Hur NW; Kim J; Lee SY; Jung SH; Nam CM
    J Prev Med Public Health; 2006 Jul; 39(4):346-52. PubMed ID: 16910309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.
    Weedon-Fekjaer H; Vatten LJ; Aalen OO; Lindqvist B; Tretli S
    J Med Screen; 2005; 12(4):172-8. PubMed ID: 16417693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
    Bordás P; Jonsson H; Nyström L; Lenner P
    J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.
    Wu JC; Hakama M; Anttila A; Yen AM; Malila N; Sarkeala T; Auvinen A; Chiu SY; Chen HH
    Breast Cancer Res Treat; 2010 Jul; 122(2):553-66. PubMed ID: 20054645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
    Shen Y; Parmigiani G
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening and the increase in breast cancer incidence in Hawaii.
    Maskarinec G; Wilkens L; Meng L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):201-8. PubMed ID: 9138664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of age-specific sensitivity and sojourn time in breast cancer screening studies.
    Cong XJ; Shen Y; Miller AB
    Stat Med; 2005 Oct; 24(20):3123-38. PubMed ID: 15977269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening.
    Weedon-Fekjaer H; Lindqvist BH; Vatten LJ; Aalen OO; Tretli S
    J Med Screen; 2008; 15(2):83-90. PubMed ID: 18573776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer incidence after the introduction of mammography screening: what should be expected?
    Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
    Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
    McCann J; Treasure P; Duffy S
    J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early breast cancer detection.
    Foti E; Mancuso S
    Minerva Ginecol; 2005 Jun; 57(3):269-92. PubMed ID: 16166936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
    Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screenings.
    Baker SG
    Biometrics; 1998 Dec; 54(4):1569-78. PubMed ID: 9883553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of mammography in different ethnic groups in Israel--analysis of mortality reduction and costs using CAN*TROL.
    Rennert G
    Cancer Detect Prev; 1991; 15(6):477-81. PubMed ID: 1723656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.